1.
G Trape, L Fianchi, M Lai, L Laurenti, R Piscitelli, G Leone, L Pagano. Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders. haematol [Internet]. 2003Feb.1 [cited 2024Mar.29];88(2):223-5. Available from: https://haematologica.org/article/view/2634